Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitrectomy Combined With Intravitreal Dexamethasone Implant for the Treatment of Idiopathic Epiretinal Membrane With Cystoid Macular Oedema

NCT06232616 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.

NCT NCT06232616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitrectomy Combined With Intravitreal Dexamethasone Implant for the Treatment of Idiopathic Epiretinal Membrane With Cystoid Macular Oedema
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 11, 2024
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epiretinal membrane